MEDP:NGS-Medpace Holdings Inc. (USD)

EQUITY | Diagnostics & Research | Nasdaq Global Select

Last Closing

USD 332.23

Change

0.00 (0.00)%

Market Cap

USD 1.47B

Volume

0.15M

Analyst Target

USD 118.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-01 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IDXX IDEXX Laboratories Inc

+6.68 (+1.63%)

USD 35.79B
ILMN Illumina Inc

+5.08 (+3.88%)

USD 23.01B
NTRA Natera Inc

+7.00 (+4.36%)

USD 22.06B
ICLR ICON PLC

+0.65 (+0.31%)

USD 17.53B
EXAS EXACT Sciences Corporation

+0.33 (+0.57%)

USD 10.65B
RDNT RadNet Inc

+1.36 (+1.94%)

USD 5.28B
GH Guardant Health Inc

+1.99 (+6.26%)

USD 3.91B
SHC Sotera Health Co

+0.01 (+0.07%)

USD 3.72B
VCYT Veracyte Inc

+1.47 (+3.64%)

USD 3.11B
TWST Twist Bioscience Corp

+2.02 (+4.46%)

USD 2.85B

ETFs Containing MEDP

AJEUAS:SW UBS (Irl) Fund Solutions .. 96.30 % 0.00 %

+1.24 (+1.29%)

N/A
ZCLN:CA BMO Clean Energy Index ET.. 3.87 % 0.00 %

+0.12 (+1.29%)

CAD 0.06B
XCLN:CA iShares Global Clean Ener.. 3.86 % 0.00 %

+0.04 (+1.29%)

CAD 8.46M
INRE:PA iShares Global Clean Ener.. 3.86 % 0.00 %

-0.02 (1.29%)

N/A
ICLN iShares Global Clean Ener.. 3.84 % 0.46 %

+0.05 (+1.29%)

USD 1.44B
AMID Argent Mid Cap ETF 3.71 % 0.00 %

+0.36 (+1.29%)

N/A
EUDV:SW SPDR® S&P Euro Dividend .. 3.48 % 0.00 %

N/A

N/A
FNRG:LSE Fidelity Clean Energy UCI.. 2.71 % 0.00 %

+0.03 (+1.29%)

USD 9.75M
STUX:SW SPDR® MSCI Europe Utilit.. 2.55 % 0.00 %

+3.92 (+1.29%)

USD 0.12B
QSML:AU VanEck MSCI International.. 1.45 % 0.00 %

-0.12 (1.29%)

N/A
RFG Invesco S&P MidCap 400® .. 0.00 % 0.35 %

+0.61 (+1.29%)

N/A
JSMD Janus Henderson Small/Mid.. 0.00 % 0.50 %

+0.86 (+1.29%)

USD 0.42B
SMLF iShares MSCI USA Small-Ca.. 0.00 % 0.30 %

+0.83 (+1.29%)

N/A
INRG:LSE iShares Global Clean Ener.. 0.00 % 0.00 %

+0.25 (+1.29%)

N/A
L6EW:LSE Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

-60.00 (1.29%)

USD 0.11B
LCPE:LSE Ossiam Shiller Barclays C.. 0.00 % 0.00 %

-475.00 (1.29%)

USD 0.12B
S6EW:LSE Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

-0.74 (1.29%)

N/A
JELS:LSE 0.00 % 0.00 %

N/A

N/A
UTIL:LSE SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

+0.40 (+1.29%)

USD 0.12B
S6EW:PA Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

-0.72 (1.29%)

USD 0.11B
STU:PA SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

+0.54 (+1.29%)

USD 0.12B
IQQH:F iShares Global Clean Ener.. 0.00 % 0.00 %

+0.07 (+1.29%)

N/A
OSX6:F Ossiam Lux - Ossiam Stoxx.. 0.00 % 0.00 %

+0.16 (+1.29%)

N/A
SPYU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+1.80 (+1.29%)

N/A
SPYW:F SPDR S&P Euro Dividend Ar.. 0.00 % 0.00 %

+0.04 (+1.29%)

N/A
DXSH:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

-0.88 (1.29%)

USD 0.03B
IQQH:XETRA iShares Global Clean Ener.. 0.00 % 0.00 %

-0.01 (1.29%)

USD 3.34B
OSX6:XETRA Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

+0.20 (+1.29%)

USD 0.16B
SPYU:XETRA SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

+0.38 (+1.29%)

USD 0.16B
IBBJ 0.00 % 0.00 %

N/A

N/A
VCLN Virtus Duff & Phelps Clea.. 0.00 % 0.00 %

+0.29 (+1.29%)

USD 5.68M

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 12.19% 77% C+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.19% 77% C+ 63% D
Trailing 5 Years  
Capital Gain 302.56% 97% N/A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 302.56% 97% N/A 95% A
Average Annual (5 Year Horizon)  
Capital Gain 43.25% 73% C 85% B
Dividend Return 43.25% 73% C 85% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 39.91% 77% C+ 47% F
Risk Adjusted Return 108.37% 100% F 98% N/A
Market Capitalization 1.47B 90% A- 93% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 128.40 43% 32%
Price/Book Ratio 12.20 12% 11%
Price / Cash Flow Ratio 24.81 14% 13%
Price/Free Cash Flow Ratio 23.37 18% 17%
Management Effectiveness  
Return on Equity 54.08% 98% 98%
Return on Invested Capital 57.06% 100% 95%
Return on Assets 14.31% 98% 98%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.